well in that case you must be saying the current CEO is a donkey , he mentioned clearly RCT is needed in his recent business update!
I don’t think you really understand the importance of RCT and what’s it’s intended to prove because you seem to think Panco is enough and has proved the device. It didn’t.
this therasphere news isn’t relevant to OncoSil. Therasphere had HDE since 1999, did more trials (the newspiece mentions an earlier RCT, and now they’ve a full fda approval.
Theraspheres and FDA approval, page-3
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.38M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $71.81K | 11.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 10730612 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 9523384 | 12 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |